APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunotherapeutic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Immunotherapeutic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchImmunotherapeutic Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunotherapeutic Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Immunotherapeutic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunotherapeutic Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunotherapeutic Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Immunotherapeutic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Immunotherapeutic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunotherapeutic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunotherapeutic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immunotherapeutic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunotherapeutic Drugs include Johnson & Johnson, Novartis, Merck, Roche, ELI Lilly, GlaxoSmithKline, Amgen, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Immunotherapeutic Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunotherapeutic Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunotherapeutic Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Immunotherapeutic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunotherapeutic Drugs Segment by Company

Johnson & Johnson

Novartis

Merck

Roche

ELI Lilly

GlaxoSmithKline

Amgen

AbbVie

AstraZeneca

Bristol-Mysers Squibb

Immunotherapeutic Drugs Segment by Type

Monoclonal Antibody

Interferon

Checkpoint Inhibitor

Vaccines

Immunotherapeutic Drugs Segment by Application

Hospitals

Clinics

Other

Immunotherapeutic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunotherapeutic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunotherapeutic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunotherapeutic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Immunotherapeutic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunotherapeutic Drugs industry.

Chapter 3: Detailed analysis of Immunotherapeutic Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunotherapeutic Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Monoclonal Antibody Table 3. Key Players of Interferon Table 4. Key Players of Checkpoint Inhibitor Table 3. Key Players of Vaccines Table 4. Global Immunotherapeutic Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Clinics Table 7. Key Players of Other Table 8. Global Immunotherapeutic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Immunotherapeutic Drugs Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Immunotherapeutic Drugs Market Share by Region (2021-2026) Table 11. Global Immunotherapeutic Drugs Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Immunotherapeutic Drugs Market Share by Region (2027-2032) Table 13. Immunotherapeutic Drugs Industry Trends Table 14. Immunotherapeutic Drugs Industry Drivers Table 15. Immunotherapeutic Drugs Industry Opportunities and Challenges Table 16. Immunotherapeutic Drugs Industry Restraints Table 17. Global Immunotherapeutic Drugs Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Immunotherapeutic Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Immunotherapeutic Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Immunotherapeutic Drugs Key Company Head Office and Area Served Table 21. Global Immunotherapeutic Drugs Company, Product Type & Application Table 22. Global Immunotherapeutic Drugs Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Immunotherapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Immunotherapeutic Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Immunotherapeutic Drugs Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Immunotherapeutic Drugs Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Immunotherapeutic Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Immunotherapeutic Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Immunotherapeutic Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Immunotherapeutic Drugs Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Immunotherapeutic Drugs Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Immunotherapeutic Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Immunotherapeutic Drugs Revenue Market Share by Application (2027-2032) Table 35. Johnson & Johnson Company Information Table 36. Johnson & Johnson Business Overview Table 37. Johnson & Johnson Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Johnson & Johnson Immunotherapeutic Drugs Product Portfolio Table 39. Johnson & Johnson Recent Development Table 40. Novartis Company Information Table 41. Novartis Business Overview Table 42. Novartis Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Novartis Immunotherapeutic Drugs Product Portfolio Table 44. Novartis Recent Development Table 45. Merck Company Information Table 46. Merck Business Overview Table 47. Merck Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Merck Immunotherapeutic Drugs Product Portfolio Table 49. Merck Recent Development Table 50. Roche Company Information Table 51. Roche Business Overview Table 52. Roche Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Roche Immunotherapeutic Drugs Product Portfolio Table 54. Roche Recent Development Table 55. ELI Lilly Company Information Table 56. ELI Lilly Business Overview Table 57. ELI Lilly Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. ELI Lilly Immunotherapeutic Drugs Product Portfolio Table 59. ELI Lilly Recent Development Table 60. GlaxoSmithKline Company Information Table 61. GlaxoSmithKline Business Overview Table 62. GlaxoSmithKline Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. GlaxoSmithKline Immunotherapeutic Drugs Product Portfolio Table 64. GlaxoSmithKline Recent Development Table 65. Amgen Company Information Table 66. Amgen Business Overview Table 67. Amgen Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Amgen Immunotherapeutic Drugs Product Portfolio Table 69. Amgen Recent Development Table 70. AbbVie Company Information Table 71. AbbVie Business Overview Table 72. AbbVie Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. AbbVie Immunotherapeutic Drugs Product Portfolio Table 74. AbbVie Recent Development Table 75. AstraZeneca Company Information Table 76. AstraZeneca Business Overview Table 77. AstraZeneca Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. AstraZeneca Immunotherapeutic Drugs Product Portfolio Table 79. AstraZeneca Recent Development Table 80. Bristol-Mysers Squibb Company Information Table 81. Bristol-Mysers Squibb Business Overview Table 82. Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Bristol-Mysers Squibb Immunotherapeutic Drugs Product Portfolio Table 84. Bristol-Mysers Squibb Recent Development Table 85. North America Immunotherapeutic Drugs Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Immunotherapeutic Drugs Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Immunotherapeutic Drugs Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Immunotherapeutic Drugs Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Immunotherapeutic Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Immunotherapeutic Drugs Market Size by Country (2021-2026) Table 91. North America Immunotherapeutic Drugs Market Size by Country (2027-2032) Table 92. Europe Immunotherapeutic Drugs Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Immunotherapeutic Drugs Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Immunotherapeutic Drugs Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Immunotherapeutic Drugs Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Immunotherapeutic Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Immunotherapeutic Drugs Market Size by Country (2021-2026) Table 98. Europe Immunotherapeutic Drugs Market Size by Country (2027-2032) Table 99. China Immunotherapeutic Drugs Market Size by Type (2021-2026) & (US$ Million) Table 100. China Immunotherapeutic Drugs Market Size by Type (2027-2032) & (US$ Million) Table 101. China Immunotherapeutic Drugs Market Size by Application (2021-2026) & (US$ Million) Table 102. China Immunotherapeutic Drugs Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Immunotherapeutic Drugs Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Immunotherapeutic Drugs Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Immunotherapeutic Drugs Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Immunotherapeutic Drugs Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Immunotherapeutic Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Immunotherapeutic Drugs Market Size by Country (2021-2026) Table 109. Asia Immunotherapeutic Drugs Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Immunotherapeutic Drugs Product Image Figure 2. Global Immunotherapeutic Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Immunotherapeutic Drugs Market Share by Type: 2025 VS 2032 Figure 4. Monoclonal Antibody Image Figure 5. Interferon Image Figure 6. Checkpoint Inhibitor Image Figure 7. Vaccines Image Figure 8. Global Immunotherapeutic Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Immunotherapeutic Drugs Market Share by Application: 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Clinics Image Figure 12. Other Image Figure 13. Global Immunotherapeutic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 15. Global Immunotherapeutic Drugs Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Immunotherapeutic Drugs Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Immunotherapeutic Drugs Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Immunotherapeutic Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Immunotherapeutic Drugs Revenue Market Share by Type (2021-2032) Figure 22. Global Immunotherapeutic Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Immunotherapeutic Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 25. North America Immunotherapeutic Drugs Market Share by Type (2021-2032) Figure 26. North America Immunotherapeutic Drugs Market Share by Application (2021-2032) Figure 27. North America Immunotherapeutic Drugs Market Share by Country (2021-2032) Figure 28. United States Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Canada Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Immunotherapeutic Drugs Market Share by Type (2021-2032) Figure 33. Europe Immunotherapeutic Drugs Market Share by Application (2021-2032) Figure 34. Europe Immunotherapeutic Drugs Market Share by Country (2021-2032) Figure 35. Germany Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 36. France Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Italy Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Russia Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Immunotherapeutic Drugs Market Share by Type (2021-2032) Figure 43. China Immunotherapeutic Drugs Market Share by Application (2021-2032) Figure 44. Asia Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 45. Asia Immunotherapeutic Drugs Market Share by Type (2021-2032) Figure 46. Asia Immunotherapeutic Drugs Market Share by Application (2021-2032) Figure 47. Asia Immunotherapeutic Drugs Market Share by Country (2021-2032) Figure 48. Japan Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 52. India Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Australia Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Immunotherapeutic Drugs Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Immunotherapeutic Drugs Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Immunotherapeutic Drugs Market Share by Country (2021-2032) Figure 58. Brazil Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 63. UAE Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Chile Immunotherapeutic Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibody
  • Interferon
  • Checkpoint Inhibitor
  • Vaccines
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • ELI Lilly
  • GlaxoSmithKline
  • Amgen
  • AbbVie
  • AstraZeneca
  • Bristol-Mysers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal Antibody
  5. 1.2.3 Interferon
  6. 1.2.4 Checkpoint Inhibitor
  7. 1.2.5 Vaccines
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Clinics
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Immunotherapeutic Drugs Growth Trends by Region
  15. 1.5.1 Global Immunotherapeutic Drugs Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Immunotherapeutic Drugs Market Size by Region (2021-2026)
  17. 1.5.3 Immunotherapeutic Drugs Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Immunotherapeutic Drugs Market Dynamics
  1. 2.1 Immunotherapeutic Drugs Industry Trends
  2. 2.2 Immunotherapeutic Drugs Industry Drivers
  3. 2.3 Immunotherapeutic Drugs Industry Opportunities and Challenges
  4. 2.4 Immunotherapeutic Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Immunotherapeutic Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Immunotherapeutic Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Immunotherapeutic Drugs Key Company Head office and Area Served
  4. 3.4 Global Immunotherapeutic Drugs Company, Product Type & Application
  5. 3.5 Global Immunotherapeutic Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Immunotherapeutic Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Immunotherapeutic Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Immunotherapeutic Drugs Tier 1, Tier 2, and Tier 3
4 Immunotherapeutic Drugs Market by Type
  1. 4.1 Global Immunotherapeutic Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Immunotherapeutic Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Immunotherapeutic Drugs Market Size Share by Type (2021-2032)
5 Immunotherapeutic Drugs Market by Application
  1. 5.1 Global Immunotherapeutic Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Immunotherapeutic Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Immunotherapeutic Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Johnson & Johnson Immunotherapeutic Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis Immunotherapeutic Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck Immunotherapeutic Drugs Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Roche Immunotherapeutic Drugs Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 ELI Lilly
  26. 6.5.1 ELI Lilly Company Information
  27. 6.5.2 ELI Lilly Business Overview
  28. 6.5.3 ELI Lilly Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 ELI Lilly Immunotherapeutic Drugs Product Portfolio
  30. 6.5.5 ELI Lilly Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GlaxoSmithKline Immunotherapeutic Drugs Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Amgen
  38. 6.7.1 Amgen Company Information
  39. 6.7.2 Amgen Business Overview
  40. 6.7.3 Amgen Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Amgen Immunotherapeutic Drugs Product Portfolio
  42. 6.7.5 Amgen Recent Developments
  43. 6.8 AbbVie
  44. 6.8.1 AbbVie Company Information
  45. 6.8.2 AbbVie Business Overview
  46. 6.8.3 AbbVie Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 AbbVie Immunotherapeutic Drugs Product Portfolio
  48. 6.8.5 AbbVie Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AstraZeneca Immunotherapeutic Drugs Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Bristol-Mysers Squibb
  56. 6.10.1 Bristol-Mysers Squibb Company Information
  57. 6.10.2 Bristol-Mysers Squibb Business Overview
  58. 6.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bristol-Mysers Squibb Immunotherapeutic Drugs Product Portfolio
  60. 6.10.5 Bristol-Mysers Squibb Recent Developments
7 North America
  1. 7.1 North America Immunotherapeutic Drugs Market Size (2021-2032)
  2. 7.2 North America Immunotherapeutic Drugs Market Size by Type
  3. 7.2.1 North America Immunotherapeutic Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Immunotherapeutic Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Immunotherapeutic Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Immunotherapeutic Drugs Market Size by Application
  7. 7.3.1 North America Immunotherapeutic Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Immunotherapeutic Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Immunotherapeutic Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Immunotherapeutic Drugs Market Size by Country
  11. 7.4.1 North America Immunotherapeutic Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Immunotherapeutic Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Immunotherapeutic Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Immunotherapeutic Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Immunotherapeutic Drugs Market Size (2021-2032)
  2. 8.2 Europe Immunotherapeutic Drugs Market Size by Type
  3. 8.2.1 Europe Immunotherapeutic Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Immunotherapeutic Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Immunotherapeutic Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Immunotherapeutic Drugs Market Size by Application
  7. 8.3.1 Europe Immunotherapeutic Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Immunotherapeutic Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Immunotherapeutic Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Immunotherapeutic Drugs Market Size by Country
  11. 8.4.1 Europe Immunotherapeutic Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Immunotherapeutic Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Immunotherapeutic Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Immunotherapeutic Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Immunotherapeutic Drugs Market Size (2021-2032)
  2. 9.2 China Immunotherapeutic Drugs Market Size by Type
  3. 9.2.1 China Immunotherapeutic Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Immunotherapeutic Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Immunotherapeutic Drugs Market Share by Type (2021-2032)
  6. 9.3 China Immunotherapeutic Drugs Market Size by Application
  7. 9.3.1 China Immunotherapeutic Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Immunotherapeutic Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Immunotherapeutic Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Immunotherapeutic Drugs Market Size (2021-2032)
  2. 10.2 Asia Immunotherapeutic Drugs Market Size by Type
  3. 10.2.1 Asia Immunotherapeutic Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Immunotherapeutic Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Immunotherapeutic Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Immunotherapeutic Drugs Market Size by Application
  7. 10.3.1 Asia Immunotherapeutic Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Immunotherapeutic Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Immunotherapeutic Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Immunotherapeutic Drugs Market Size by Country
  11. 10.4.1 Asia Immunotherapeutic Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Immunotherapeutic Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Immunotherapeutic Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Immunotherapeutic Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Immunotherapeutic Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Immunotherapeutic Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Immunotherapeutic Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Immunotherapeutic Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst